Patients with neovascular age-related macular degeneration who have a 3 month or longer lapse of anti-VEGF treatment may experience unrecoverable loss of vision, according to a study.
“We saw significant loss of vision, even for those who were initiated back on anti-VEGF therapy after these lapses,” study co-author Rishi P. Singh, MD, told Healio/OSN.
The retrospective study included 241 patients in the study group and 241 control patients. The researchers evaluated macular thickness measured by central subfield thickness (CST) and visual acuity at baseline, at the first post-lapse
Uncategorized